Client News
AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
22nd December 2021
LINDIS Biotech Announces Formation of Advisory Board to Support Next Phase of Growth
21st December 2021
ADOCIA Announces its Participation at Upcoming Investor Conferences in January 2022
20th December 2021
Atriva Therapeutics: Participation in upcoming scientific and industry conferences
20th December 2021
VisionHealth receives EU Medical Device Regulation certification
20th December 2021
MagForce AG: Enrollment in Stage 2b of Pivotal U.S. Study for the Focal Ablation of Prostate Cancer with the NanoTherm Therapy System successfully underway following IRB approval
20th December 2021
invIOs goes live with unique cell therapy platform and clinical-stage immuno-oncology pipeline
16th December 2021
Patronus Health GmbH Receives Angel Investment and Public Grant
16th December 2021
sterna biologicals announces dosing of first patient in phase IIa proof-of-concept study with SB010 in moderate to severe asthma
14th December 2021
Marinomed and Friedrich-Alexander-Universität Erlangen-Nürnberg publish new data on antiviral efficacy of iota-carrageenan against SARS-CoV-2 variants of concern
9th December 2021
There is no more content to load